EverSource Wealth Advisors’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.2K Buy
272
+69
+34% +$15.5K ﹤0.01% 1739
2025
Q4
$43.3K Sell
203
-16
-7% -$3.3K ﹤0.01% 1841
2025
Q3
$43.5K Buy
219
+8
+4% +$1.49K ﹤0.01% 1795
2025
Q2
$36.4K Sell
211
-50
-19% -$8.14K ﹤0.01% 1836
2025
Q1
$40.7K Buy
261
+49
+23% +$7K ﹤0.01% 1333
2024
Q4
$29.2K Sell
212
-3
-1% -$394 ﹤0.01% 1438
2024
Q3
$32.1K Buy
215
+1
+0.5% +$135 ﹤0.01% 1259
2024
Q2
$28.6K Buy
214
+39
+22% +$5.31K ﹤0.01% 1343
2024
Q1
$24.2K Sell
175
-158
-47% -$22.6K ﹤0.01% 1272
2023
Q4
$41.9K Buy
333
+91
+38% +$9.07K ﹤0.01% 966
2023
Q3
$22.7K Buy
242
+152
+169% +$14.2K ﹤0.01% 1081
2023
Q2
$8.03K Buy
90
+30
+50% +$2.61K ﹤0.01% 1545
2023
Q1
$6.43K Buy
60
+25
+71% +$2.86K ﹤0.01% 1553
2022
Q4
$4.28K Hold
35
﹤0.01% 1667
2022
Q3
$4K Buy
+35
New +$3.32K ﹤0.01% 1412
2022
Q1
Sell
-10
Closed -$1K 1703
2021
Q4
$1K Buy
+10
New +$1.49K ﹤0.01% 1677

Other funds holding ASND